IL23R and neoplasm: We used principal component analysis (PCA) to illustrate the ten properties (interleukin-23 receptor inhibitor, adenosine kinase, and mitotic spindle assembly protein MAD2B inhibitor, antiproliferative activity, cytotoxicity against human HCC366 cells, anticancer activity against human T47D cells, growth inhibition of human MCF7 cells, antiprogestational activity, anti-inflammatory activity, and anti-tumor activity).